PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
32.71%
Revenue growth 1.25-1.5x 6617.T's 27.45%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
18.08%
Gross profit growth above 1.5x 6617.T's 7.48%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-40.00%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-39.22%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-66.67%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-66.68%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-66.68%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.00%
Share reduction more than 1.5x 6617.T's 0.02%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.00%
Diluted share reduction more than 1.5x 6617.T's 0.02%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
85.19%
Positive 10Y revenue/share CAGR while 6617.T is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
10.64%
5Y revenue/share CAGR similar to 6617.T's 11.74%. Walter Schloss might see both companies benefiting from the same mid-term trends.
39.71%
3Y revenue/share CAGR above 1.5x 6617.T's 17.64%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-64.21%
Negative 10Y net income/share CAGR while 6617.T is at 113.29%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-76.33%
Negative 5Y net income/share CAGR while 6617.T is 67.61%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-8.36%
Negative 3Y CAGR while 6617.T is 114.28%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
117.37%
10Y equity/share CAGR above 1.5x 6617.T's 32.40%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
49.93%
5Y equity/share CAGR above 1.5x 6617.T's 28.93%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
29.33%
3Y equity/share CAGR above 1.5x 6617.T's 19.21%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.08%
AR growth is negative/stable vs. 6617.T's 22.64%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-19.39%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-6.37%
Negative asset growth while 6617.T invests at 3.12%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.14%
We have a declining book value while 6617.T shows 1.95%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-15.39%
We’re deleveraging while 6617.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
51.21%
SG&A growth well above 6617.T's 18.43%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.